Lazard Asset Management
MGNX icon

Lazard Asset Management’s MacroGenics MGNX Stock Holding History

Lazard Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-943
Closed -$1K – 2444
2025
Q1 		$1K Sell
943
-8,926
-90% -$23.3K ﹤0.01% 2254
2024
Q4 		$32K Buy
+9,869
New +$35.5K ﹤0.01% 2040
2023
Q3 		– Sell
-3,315
Closed -$17K – 2399
2023
Q2 		$17K Sell
3,315
-10,147
-75% -$62.6K ﹤0.01% 2128
2023
Q1 		$96K Buy
13,462
+1,389
+12% +$8.37K ﹤0.01% 1542
2022
Q4 		$80K Buy
+12,073
New +$66.2K ﹤0.01% 1610
2021
Q4 		– Sell
-2,098
Closed -$43K – 2394
2021
Q3 		$43K Buy
+2,098
New +$50.5K ﹤0.01% 1750
2021
Q2 		– Sell
-2,393
Closed -$76K – 2028
2021
Q1 		$76K Buy
+2,393
New +$58.1K ﹤0.01% 1275

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lazard Asset Management's MGNX Position: Q2 2025 in Review

Lazard Asset Management sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 943 shares — an estimated $1K sold.

Lazard Asset Management first reported a position in MGNX in Q1 2021 and held it in 7 quarters. The position peaked at $96K in Q1 2023. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • Lazard Asset Management reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 943 MacroGenics shares in Q2 2025, an estimated $1K.
  • Lazard Asset Management first reported a position in MacroGenics in Q1 2021 and held it in 7 quarters.
  • Lazard Asset Management's MacroGenics position peaked at $96K in Q1 2023.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.